Wuhan’s pet health firm receives new investment
COLDSKY.CN – Pet health brand Best Care(倍珍保) of Wuhan Yanxin Biotechnology Co., Ltd.(武汉研欣生物科技) received the investment of tens of millions of yuan from Qingsong Fund(青松基金) and Shangcheng Investment(尚承投资).
The brand launched in July 2019 covers functional products for pet health and care, a field underdeveloped in China despite the rapid rise of pets population. The company’s five products include one to relieve pet’s tear staining and overcome bad breath, according to 36kr.com. (https://36kr.com/p/835963677522312)
The company’s chief research advisor is Professor Ding Mingxing from the Central China Agricultural University, who has many years of experience in teaching, research, clinical practice of clinical veterinary medicine.
Su Wei, partner of Qingsong Fund, said the pet health market kept an average growth of 20 percent in the past five years but most products are exported from other countries.